Yuma News
FSIS Releases Annual Plans on Microbiological and Chemical Residue Sampling Programs
- Details
- Written by YNN YNN
- Published: 02 December 2018 02 December 2018
Washington, DC - The U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) released today the Annual Sampling Program Plan and Residue Sampling Plans for fiscal year 2019 and its first 2018 Annual Catalog of FSIS Sampling Projects.
Rain Event may be on Arizona's Horizon
- Details
- Written by National Weather Service National Weather Service
- Published: 02 December 2018 02 December 2018
Yuma, Arizona - A strong and wet Pacific upper low is expected to move into the area later this week, beginning on Wednesday afternoon with scattered to numerous showers spreading east and into Arizona by Thursday.
Del Sol Market Graffiti Hate Crime
- Details
- Written by YPD YPD
- Published: 01 December 2018 01 December 2018
Yuma, Arizona - Between 10:00pm last night and today at 7:00am, an unknown person(s) painted racially derogatory remarks in spray paint on a custom mural located at the Del Sol Market at 280 S. 4th Avenue.
Addressing heart disease, brain health and diabetes is critical to reducing deaths
- Details
- Written by Cathy Lewis Cathy Lewis
- Published: 01 December 2018 01 December 2018
Dallas, Texas - Heart disease remains the leading cause of death in the U.S. and stroke continues to rank fifth, according to the National Center for Health Statistics Mortality Data Report for 2017.
FDA approves treatment for adult patients who have relapsed or refractory acute myeloid leukemia
- Details
- Written by Amanda Turney Amanda Turney
- Published: 01 December 2018 01 December 2018
Washington, DC - The U.S. Food and Drug Administration today approved Xospata (gilteritinib) tablets for the treatment of adult patients who have relapsed or refractory acute myeloid leukemia (AML) with a FLT3 mutation as detected by an FDA-approved test. The FDA also approved an expanded indication for a companion diagnostic, to include use with Xospata.
Treatment for preeclampsia effective in animals, NIH-funded researchers show
- Details
- Written by YNN YNN
- Published: 01 December 2018 01 December 2018
Washington, DC - In studies of mice and nonhuman primates, researchers funded by the National Institutes of Health have used a technique known as RNA interference to reduce high levels of a protein that can cause preeclampsia, a potentially fatal high blood pressure disorder of pregnancy.
President Donald J. Trump and First Lady Melania Trump on the Passing of Former President George H.W. Bush
- Details
- Written by White House White House
- Published: 01 December 2018 01 December 2018
Washington, DC - Statement from President Donald J. Trump and First Lady Melania Trump on the Passing of Former President George H.W. Bush: